NCT01855373View on ClinicalTrials.gov

Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Blood SugarEndothelial Function
Interventions
DIETARY_SUPPLEMENT

PEAK ATP® with GlycoCarn®

PEAK ATP® with GlycoCarn® {Glycine Propionyl-L-Carnitine Hydrochloride, USP (500mg/capsule) and Adenosine 5'-Triphosphate Disodium Salt (100mg/capsule)}: 2 capsules twice daily on an empty stomach

DIETARY_SUPPLEMENT

PEAK ATP®

PEAK ATP® (Adenosine 5'-Triphosphate Disodium Salt (100mg/capsule): 2 capsules twice daily on an empty stomach

DIETARY_SUPPLEMENT

GlycoCarn®

GlycoCarn® (Glycine Propionyl-L-Carnitine Hydrochloride, USP (500mg/capsule): 2 capsules twice daily on an empty stomach

OTHER

Placebo

Placebo: 2 capsules twice daily on an empty stomach

Trial Locations (1)

33308

Life Extension Clinical Research Inc., Fort Lauderdale

All Listed Sponsors
collaborator

Sigma Tau HealthScience LLC

UNKNOWN

collaborator

TSI Health Sciences, Inc.

OTHER

lead

Supplement Formulators, Inc.

INDUSTRY

NCT01855373 - Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements | Biotech Hunter | Biotech Hunter